Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma

  1. Mateos, M.-V.
  2. Dimopoulos, M.A.
  3. Cavo, M.
  4. Suzuki, K.
  5. Jakubowiak, A.
  6. Knop, S.
  7. Doyen, C.
  8. Lucio, P.
  9. Nagy, Z.
  10. Kaplan, P.
  11. Pour, L.
  12. Cook, M.
  13. Grosicki, S.
  14. Crepaldi, A.
  15. Liberati, A.M.
  16. Campbell, P.
  17. Shelekhova, T.
  18. Yoon, S.-S.
  19. Iosava, G.
  20. Fujisaki, T.
  21. Garg, M.
  22. Chiu, C.
  23. Wang, J.
  24. Carson, R.
  25. Crist, W.
  26. Deraedt, W.
  27. Nguyen, H.
  28. Qi, M.
  29. San-Miguel, J.
  30. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2018

Volume: 378

Issue: 6

Pages: 518-528

Type: Article

DOI: 10.1056/NEJMOA1714678 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals